The clinical trial process has been undergoing substantial change in recent years – even more particularly in the past 12 months. The first signs of the evolution began in the 2000s when protocol complexity significantly increased. Michelle Lynskey at ICON plc. examines the critical delivery elements required from interactive response technology (IRT) providers to support this evolution, with particular focus on the needs of COVID trials.